- **Short-term implications**: The company's strong first-quarter performance, driven by new product launches and vaccine sales, is likely to boost the stock price in the short term. However, the guidance for the rest of the year is cautious, with a focus on cost containment and maintaining profit margins. The company's pipeline and growth prospects are promising, but the execution of these plans will be crucial for long-term success.
- **Rating**: 1